Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth
The Bristol Myers Squibb Q3 2026 results lift revenue guidance as newer drugs grow 12%. EPS fell on a $1.6 billion charge.
Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth
The Bristol Myers Squibb Q3 2026 results lift revenue guidance as newer drugs grow 12%. EPS fell on a $1.6 billion charge.
Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million
The Laurus Labs Galenvs acquisition buys 60% of a Montréal biotech for US$3.75 million. Terms, technology and what is undisclosed.
Fortis Healthcare Acquires Suguna Hospital in Bengaluru for ₹277 Crore
The Fortis Healthcare acquisition of Suguna Hospital in Bengaluru costs about ₹277 crore. Deal terms, beds, revenue and what is undisclosed.
Ro Launches Robin AI Health Agent to Personalise Medication and Patient Care Recommendations
What the Ro Robin AI health agent is reported to do, which data it uses and the privacy and safety questions the sources leave open.
Laurus Labs Q2 Results: Net Profit Surges 126% to ₹441 Crore as Revenue Grows 33%
The Laurus Labs Q2 results show profit up 126% to ₹441 crore on 33% revenue growth. What drove it and what the company has not said.
India Rejects TB Alliance Patent Bid for BPaL Tuberculosis Treatment, Opening Door to Generic Competition
Why the BPaL TB regimen patent India ruling matters: the Patent Office rejected TB Alliance’s application. What it means and what is unknown.
FDA Issues Medline Bed Safety Alert After 2 Deaths and 16 Serious Injuries Reported
The FDA Medline bed alert covers all Medline-brand beds after two deaths and 16 serious injuries. What owners and facilities are told to do.
Eli Lilly Q3 Revenue Jumps 39% as Mounjaro and Zepbound Sales Lift 2026 Forecast
The Eli Lilly Q3 2026 results show revenue up 39% to $24.4 billion and a higher revenue outlook, but lower EPS guidance after acquisition charges.
Hibsago (Bepirovirsen): Key Trends and Developments in Chronic Hepatitis B Treatment
The bepirovirsen Hibsago key trends: finite therapy, testing-gated use, safety monitoring and a staggered rollout, with the facts and the gaps.
FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development
The FDA ICH M15 guidance sets harmonised principles for model-informed drug development; a stakeholder webinar was set for 29 October 2026.